As we saw in the other saphenous vein graft (SVG) disease trials (CardioShield Application Protects During Transluminal Intervention of Vein Grafts by Reducing Emboli [CAPTIVE] and the Protection ...

January 20, 2009 (Washington, DC) — A new, self-expanding, drug-eluting stent with a flared configuration has proved itself to be safe and effective in bifurcated lesions, at least out to nine months, ...

Percutaneous coronary intervention (PCI) with stenting is increasingly being utilized for acute coronary syndromes (ACS), and the debate over the safety and efficacy of drug-eluting stents (DESs) ...

Abbreviated dual antiplatelet therapy after percutaneous coronary intervention using third-generation stents remained ...

APPOSITION IV trial demonstrated superior apposition and faster healing than with conventional stents PRINCETON, N.J. and PARIS ., STENTYS, a medical technology company commercializing the world's ...

Please provide your email address to receive an email when new articles are posted on . Since the beginning of stent use, patients have received a “stent card” after PCI with information about their ...

A research team has demonstrated that clopidogrel is more effective than aspirin as a long-term antiplatelet therapy in ...

Results from an Angiographic Analysis of the CHAMPION PHOENIX Trial Presented at ACC.14 WASHINGTON, DC – A new angiographic analysis of the CHAMPION PHOENIX trial examined the incidence and impact of ...

When someone comes in for a new heart stent, it's critical that the medical team doing the procedure knows several key facts about previous stents the patient has had. But fewer than half of patients ...

Drug-coated balloons are gaining attention as a stent-free angioplasty option, offering a “leave nothing behind” approach ...